The application of magnetic nanoparticles for the treatment of brain tumors

Frontiers in Chemistry

Volumn 2, Issue DEC, 2014, Pages

  Mahmoudi, Keon ^a   Hadjipanayis, Costas G ^b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glioblastoma; Hyperthermia; Imaging; Magnetic nanoparticles; Nanoparticles; Nanotheranostics

Indexed keywords

EID: 84987602322     PISSN: None     EISSN: 22962646     Source Type: Journal    
DOI: 10.3389/fchem.2014.00109     Document Type: Note

References (43)

1. Adamson, C., Kanu, O. O., Mehta, A. I., Di, C., Lin, N., Mattox, A. K., et al. (2009). Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin. Investig. Drugs 18, 1061-1083. doi: 10.1517/13543780903052764
2. Batchelor, T. T., Sorensen, A. G., Di Tomaso, E., Zhang, W. T., Duda, D. G., Cohen, K. S., et al. (2007). AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11, 83-95. doi: 10.1016/j.ccr.2006.11.021
3. Bidros, D. S., and Vogelbaum, M. A. (2009). Novel drug delivery strategies in neuro-oncology. Neurotherapeutics 6, 539-546. doi: 10.1016/j.nurt.2009.04.004
4. Braun, S., Oppermann, H., Mueller, A., Renner, C., Hovhannisyan, A., Baran-Schmidt, R., et al. (2012). Hedgehog signaling in glioblastoma multiforme. Cancer Biol. Ther. 13, 487-495. doi: 10.4161/cbt.19591
5. Chertok, B., Moffat, B. A., David, A. E., Yu, F., Bergemann, C., Ross, B. D., et al. (2008). Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 29, 487-496. doi: 10.1016/j.biomaterials.2007.08.050
6. Deissler, R. J., Wu, Y., and Martens, M. A. (2014). Dependence of brownian and neel relaxation times on magnetic field strength. Med. Phys. 41, 012301. doi: 10.1118/1.4837216
7. Fajardo, L. F. (1984). Pathological effects of hyperthermia in normal tissues. Cancer Res. 44, 4826s-4835s.
8. Gahramanov, S., Raslan, A. M., Muldoon, L. L., Hamilton, B. E., Rooney, W. D., Varallyay, C. G., et al. (2011). Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study. Int. J. Radiat. Oncol. Biol. Phys. 79, 514-523. doi: 10.1016/j.ijrobp.2009.10.072
9. Gambarota, G., and Leenders, W. (2011). Characterization of tumor vasculature in mouse brain by USPIO contrast-enhanced MRI. Methods Mol. Biol. 771, 477-487. doi: 10.1007/978-1-61779-219-9_25
10. Guedes, M. H. A., Guedes, M. E. A., Morais, P. C., Da Silva, M. F., Santos, T. S., Alves, J. P. Jr., et al. (2004). Proposal of a magnetohyperthermia system: preliminary biological tests. J. Magn. Magn. Mat. 272-276(Pt 3), 2406-2407. doi: 10.1016/j.jmmm.2003.12.709
11. Hadjipanayis, C. G., Bouras, A., and Chang, S. (2013). Applications of multifunctional nanoparticles in malignant brain tumours. Eur. Assoc. Neurooncol. Mag. 4, 9-15.
12. Hadjipanayis, C. G., Machaidze, R., Kaluzova, M., Wang, L., Schuette, A. J., Chen, H., et al. (2010). EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res. 70, 6303-6312. doi: 10.1158/0008-5472
13. Hou, L. C., Veeravagu, A., Hsu, A. R., and Tse, V. C. (2006). Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg. Focus 20, E5. doi: 10.3171/foc.2006.20.4.2
14. Issels, R. D. (2008). Hyperthermia adds to chemotherapy. Eur. J. Cancer 44, 2546-2554. doi: 10.1016/j.ejca.2008.07.038
15. Jain, R. K. (2001). Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat. Med. 7, 987-989. doi: 10.1038/nm0901-987
16. Jain, R. K. (2005). Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58-62. doi: 10.1126/science.1104819
17. Johnson, D., and O'Neill, B. (2012). Glioblastoma survival in the United States before and during the temozolomide era. J. Neuro Oncol. 107, 359-364. doi: 10.1007/s11060-011-0749-4
18. Jordan, A., Scholz, R., Wust, P., Fähling, H., and Roland, F. (1999). Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J. Magn. Magn. Mat. 201, 413-419. doi: 10.1016/S0304-8853(99)00088-8
19. Kampinga, H. H. (2006). Cell biological effects of hyperthermia alone or combined with radiation or drugs: a short introduction to newcomers in the field. Int. J. Hyperthermia 22, 191-196. doi: 10.1080/02656730500532028
20. Kim, S.-S., Rait, A., Kim, E., Pirollo, K. F., Nishida, M., Farkas, N., et al. (2014). A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival. ACS Nano 8, 5494-5514. doi: 10.1021/nn5014484
21. Kumar, M., Medarova, Z., Pantazopoulos, P., Dai, G., and Moore, A. (2010). Novel membrane-permeable contrast agent for brain tumor detection by MRI. Magn. Reson. Med. 63, 617-624. doi: 10.1002/mrm.22216
22. Liu, H.-L., Hua, M.-Y., Yang, H.-W., Huang, C.-Y., Chu, P.-C., Wu, J.-S., et al. (2010). Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc. Natl. Acad. Sci. U.S.A. 107, 15205-15210. doi: 10.1073/pnas.1003388107
23. Loehrer, P. J. Sr. Feng, Y., Cardenes, H., Wagner, L., Brell, J. M., Cella, D., et al. (2011). Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an eastern cooperative oncology group trial. J. Clin. Oncol. 29, 4105-4112. doi: 10.1200/JCO.2011.34.8904
24. Mahmoudi, M., Hofmann, H., Rothen-Rutishauser, B., and Petri-Fink, A. (2012). Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem. Rev. 112, 2323-2338. doi: 10.1021/cr2002596
25. Maier-Hauff, K., Rothe, R., Scholz, R., Gneveckow, U., Wust, P., Thiesen, B., et al. (2007). Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J. Neurooncol. 81, 53-60. doi: 10.1007/s11060-006-9195-0
26. Maier-Hauff, K., Ulrich, F., Nestler, D., Niehoff, H., Wust, P., Thiesen, B., et al. (2011). Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J. Neurooncol. 103, 317-324. doi: 10.1007/s11060-010-0389-0
27. Marcos-Campos, I., Asín, L., Torres, T. E., Marquina, C., Tres, A., Ibarra, M. R., et al. (2011). Cell death induced by the application of alternating magnetic fields to nanoparticle-loaded dendritic cells. Nanotechnology 22:205101. doi: 10.1088/0957-4484/22/20/205101
28. Meenach, S. A., Hilt, J. Z., and Anderson, K. W. (2010). Poly(ethylene glycol)-based magnetic hydrogel nanocomposites for hyperthermia cancer therapy. Acta Biomater. 6, 1039-1046. doi: 10.1016/j.actbio.2009.10.017
29. Na, H. B., Lee, J. H., An, K., Park, Y. I., Park, M., Lee, I. S., et al. (2007). Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew. Chem. Int. Ed. Engl. 46, 5397-5401. doi: 10.1002/anie.200604775
30. Pankhurst, Q. A., Connolly, J., Jones, S. K., and Dobson, J. (2003). Applications of magnetic nanoparticles in biomedicine. J. Phys. D 36, R167. doi: 10.1088/0022-3727/36/13/201
31. Pu, P.-Y., Zhang, Y.-Z., and Jiang, D.-H. (2013). Apoptosis induced by hyperthermia in human glioblastoma cell line and murine glioblastoma. Chin. J. Cancer Res. 12, 257-262. doi: 10.1007/BF02983501
32. Rhee, J. G., Eddy, H. A., Harrison, G. H., and Salazar, O. M. (1990). Heat-sensitive state of mouse mammary carcinoma cells in tumors. Radiat. Res. 123, 165-170. doi: 10.2307/3577540
33. Salazar, O. M., Rubin, P., McDonald, J. V., and Feldstein, M. L. (1976). High dose radiation therapy in the treatment of glioblastoma multiforme: a preliminary report. Int. J. Radiat. Oncol. Biol. Phys. 1, 717-727. doi: 10.1016/0360-3016(76)90155-3
34. Sandhiya, S., Dkhar, S. A., and Surendiran, A. (2009). Emerging trends of nanomedicine-an overview. Fundam. Clin. Pharmacol. 23, 263-269. doi: 10.1111/j.1472-8206.2009.00692.x
35. Stupp, R., Mason, W. P., Van Den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J., et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987-996. doi: 10.1056/NEJMoa043330
36. Tajes, M., Ramos-Fernandez, E., Weng-Jiang, X., Bosch-Morato, M., Guivernau, B., Eraso-Pichot, A., et al. (2014). The blood-brain barrier: structure, function and therapeutic approaches to cross it. Mol. Membr. Biol. 31, 152-167. doi: 10.3109/09687688.2014.937468
37. Thiesen, B., and Jordan, A. (2008). Clinical applications of magnetic nanoparticles for hyperthermia. Int. J. Hyperthermia. 24, 467-474. doi: 10.1080/02656730802104757
38. Thorek, D. L., Chen, A. K., Czupryna, J., and Tsourkas, A. (2006). Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann. Biomed. Eng. 34, 23-38. doi: 10.1007/s10439-005-9002-7
39. Van Landeghem, F. K. H., Maier-Hauff, K., Jordan, A., Hoffmann, K.-T., Gneveckow, U., Scholz, R., et al. (2009). Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 30, 52-57. doi: 10.1016/j.biomaterials.2008.09.044
40. Varallyay, P., Nesbit, G., Muldoon, L. L., Nixon, R. R., Delashaw, J., Cohen, J. I., et al. (2002). Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. Am. J. Neuroradiol. 23, 510-519.
41. Wankhede, M., Bouras, A., Kaluzova, M., and Hadjipanayis, C. G. (2012). Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy. Exp. Rev. Clin. Pharmacol. 5, 173-186. doi: 10.1586/ecp.12.1
42. Wust, P., Hildebrandt, B., Sreenivasa, G., Rau, B., Gellermann, J., Riess, H., et al. (2002). Hyperthermia in combined treatment of cancer. Lancet Oncol. 3, 487-497. doi: 10.1016/S1470-2045(02)00818-5
43. Yanase, M., Shinkai, M., Honda, H., Wakabayashi, T., Yoshida, J., and Kobayashi, T. (1997). Intracellular hyperthermia for cancer using magnetite cationic liposomes: ex vivo study. Jpn. J. Cancer Res. 88, 630-632. doi: 10.1111/j.1349-7006.1997.tb00429.x